BioXcel Therapeutics (BTAI) Revenue (2022 - 2026)
BioXcel Therapeutics (BTAI) posted Revenue of $182000.0 for Q2 2026, down 11.65% on a QoQ basis from $206000.0 in Q1 2026, and up 51.67% year-over-year from $120000.0 in Q2 2025.
Powered by 
Analysis
BioXcel Therapeutics (BTAI) Revenue (2022 - 2026) Analysis & Trends
BioXcel Therapeutics has reported Revenue for 5 years, with the latest figure at $182000.0 in Q2 2026.
- On a quarterly basis, Revenue rose 51.67% year-over-year to $182000.0 in Q2 2026; TTM through Jun 2026 was $742000.0, a 14.52% decrease from a year earlier, with the FY2025 full-year figure at $642000.0, down 71.67% from the prior year.
- Revenue was $182000.0 for Q2 2026 at BioXcel Therapeutics, down from $206000.0 in the prior quarter.
- The five-year high for Revenue was $1.1 million in Q2 2024, with the low at $98000.0 in Q3 2025.
- Average Revenue over 5 years is $315687.5, with a median of $226000.0 recorded in 2022.
- The sharpest annual moves came in 2024 and 2025: Revenue surged 182.52% in 2024, then plunged 89.13% in 2025.
- Over 5 years, Revenue stood at $238000.0 in 2022, then soared by 57.98% to $376000.0 in 2023, then declined by 2.66% to $366000.0 in 2024, then sank by 30.05% to $256000.0 in 2025, then dropped by 28.91% to $182000.0 in 2026.
- The last three Revenue figures came in at $182000.0 (Q2 2026), $206000.0 (Q1 2026), and $256000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn | 10.05 Bn |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn | 7.80 Bn |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn | 3.33 Bn |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn | 4.29 Bn |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn | 145.00 Mn |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn | 1.52 Bn |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | 1.29 Bn |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | 2.74 Bn |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn | 1.44 Mn |
| 10 | BioXcel Therapeutics | 2.50 Mn | 2.50 Mn | 160,000.00 | 182,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 182,000.00 |
| Mar 31, 2026 | 206,000.00 |
| Dec 31, 2025 | 256,000.00 |
| Sep 30, 2025 | 98,000.00 |
| Jun 30, 2025 | 120,000.00 |
| Mar 31, 2025 | 168,000.00 |
| Dec 31, 2024 | 366,000.00 |
| Sep 30, 2024 | 214,000.00 |
| Jun 30, 2024 | 1.10 Mn |
| Mar 31, 2024 | 582,000.00 |
| Dec 31, 2023 | 376,000.00 |
| Sep 30, 2023 | 341,000.00 |
| Jun 30, 2023 | 457,000.00 |
| Mar 31, 2023 | 206,000.00 |
| Dec 31, 2022 | 238,000.00 |
| Sep 30, 2022 | 137,000.00 |
API Access
BioXcel Therapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=BTAI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "BTAI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=BTAI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();